Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial

Introduction Knee replacement (KR) is a clinically proven procedure typically offered to patients with severe knee osteoarthritis (OA) to relieve pain and improve quality of life. However, artificial joints fail over time, requiring revision associated with higher mortality and inferior outcomes. Wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Deborah D Stocken, Dennis G McGonagle, David Murray, Catherine Reynolds, Catherine Fernandez, David R Ellard, Andrew Metcalfe, Hemant Sharma, Paul Harwood, Hamish Simpson, Hemant Pandit, Susanne Arnold, Cerys Joyce Tassinari, Ruchi Higham, Isabelle Louise Smith, Ruben Mujica-Mota, Thomas William Hamilton, Julie Croft
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e062721.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584098974007296
author Deborah D Stocken
Dennis G McGonagle
David Murray
Catherine Reynolds
Catherine Fernandez
David R Ellard
Andrew Metcalfe
Hemant Sharma
Paul Harwood
Hamish Simpson
Hemant Pandit
Susanne Arnold
Cerys Joyce Tassinari
Ruchi Higham
Isabelle Louise Smith
Ruben Mujica-Mota
Thomas William Hamilton
Julie Croft
author_facet Deborah D Stocken
Dennis G McGonagle
David Murray
Catherine Reynolds
Catherine Fernandez
David R Ellard
Andrew Metcalfe
Hemant Sharma
Paul Harwood
Hamish Simpson
Hemant Pandit
Susanne Arnold
Cerys Joyce Tassinari
Ruchi Higham
Isabelle Louise Smith
Ruben Mujica-Mota
Thomas William Hamilton
Julie Croft
author_sort Deborah D Stocken
collection DOAJ
description Introduction Knee replacement (KR) is a clinically proven procedure typically offered to patients with severe knee osteoarthritis (OA) to relieve pain and improve quality of life. However, artificial joints fail over time, requiring revision associated with higher mortality and inferior outcomes. With more young people presenting with knee OA and increasing life expectancy, there is an unmet need to postpone time to first KR. Knee joint distraction (KJD), the practice of using external fixators to open up knee joint space, is proposed as potentially effective to preserve the joint following initial studies in the Netherlands, however, has not been researched within an NHS setting. The KARDS trial will investigate whether KJD is non-inferior to KR in terms of patient-reported postoperative pain 12 months post-surgery.Methods and analysis KARDS is a phase III, multicentre, pragmatic, open-label, individually randomised controlled non-inferiority trial comparing KJD with KR in patients with severe knee OA, employing a hybrid-expertise design, with internal pilot phase and process evaluation. 344 participants will be randomised (1:1) to KJD or KR. The primary outcome measure is the Knee Injury and Osteoarthritis Outcomes Score (KOOS) pain domain score at 12 months post-operation. Secondary outcome measures include patient-reported overall KOOS, Pain Visual Analogue Scale and Oxford Knee Scores, knee function assessments, joint space width, complications and further interventions over 24 months post-operation. Per patient cost difference between KR and KJD and cost per quality-adjusted life year (QALY) gained over 24 months will be estimated within trial, and incremental cost per QALY gained over 20 years by KJD relative to KR predicted using decision analytic modelling.Ethics and dissemination Ethics approval was obtained from the Research Ethics Committee (REC) and Health Research Authority (HRA). Trial results will be disseminated at clinical conferences, through relevant patient groups and published in peer-reviewed journals.Trial registration number ISRCTN14879004; recruitment opened April 2021.
format Article
id doaj-art-d6a86da0f1ef4c8c9fe151ff9ab8afb9
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-d6a86da0f1ef4c8c9fe151ff9ab8afb92025-01-27T20:10:10ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2022-062721Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trialDeborah D Stocken0Dennis G McGonagle1David Murray2Catherine Reynolds3Catherine Fernandez4David R Ellard5Andrew Metcalfe6Hemant Sharma7Paul Harwood8Hamish Simpson9Hemant Pandit10Susanne Arnold11Cerys Joyce Tassinari12Ruchi Higham13Isabelle Louise Smith14Ruben Mujica-Mota15Thomas William Hamilton16Julie Croft174 Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UK1 University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UKNuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, Oxfordshire, UK2University of LeedsSchool of Medicine, University of Leeds, Leeds, UKWarwick Clinical Trials Unit, University of Warwick Warwick Medical School, Coventry, UKWarwick Clinical Trials Unit, University of Warwick, Warwick Medical School, Coventry, UKTrauma and Orthopedics, Hull Royal Infirmary, Hull, UKUniversity of Leeds, Leeds Institute of Medical Research, Leeds, West Yorkshire, UKDepartment of Orthopaedics and Trauma, University of Edinburgh, Edinburgh, UK7 Leeds Biomedical Research Centre, Leeds, UKWarwick Clinical Trials Unit, University of Warwick, Coventry, UKClinical Trials Research Unit, Leeds Institute of Clinical Trials, University of Leeds, Leeds, UKClinical Trials Research Unit, Leeds Institute of Clinical Trials, University of Leeds, Leeds, UKClinical Trials Research Unit, Leeds Institute of Clinical Trials, University of Leeds, Leeds, UKLeeds Institute of Health Sciences, University of Leeds, Leeds, UK3 NDORMS, University of Oxford, Oxford, UK4 Leeds Institute for Clinical Trials Research, University of Leeds, Leeds, UKIntroduction Knee replacement (KR) is a clinically proven procedure typically offered to patients with severe knee osteoarthritis (OA) to relieve pain and improve quality of life. However, artificial joints fail over time, requiring revision associated with higher mortality and inferior outcomes. With more young people presenting with knee OA and increasing life expectancy, there is an unmet need to postpone time to first KR. Knee joint distraction (KJD), the practice of using external fixators to open up knee joint space, is proposed as potentially effective to preserve the joint following initial studies in the Netherlands, however, has not been researched within an NHS setting. The KARDS trial will investigate whether KJD is non-inferior to KR in terms of patient-reported postoperative pain 12 months post-surgery.Methods and analysis KARDS is a phase III, multicentre, pragmatic, open-label, individually randomised controlled non-inferiority trial comparing KJD with KR in patients with severe knee OA, employing a hybrid-expertise design, with internal pilot phase and process evaluation. 344 participants will be randomised (1:1) to KJD or KR. The primary outcome measure is the Knee Injury and Osteoarthritis Outcomes Score (KOOS) pain domain score at 12 months post-operation. Secondary outcome measures include patient-reported overall KOOS, Pain Visual Analogue Scale and Oxford Knee Scores, knee function assessments, joint space width, complications and further interventions over 24 months post-operation. Per patient cost difference between KR and KJD and cost per quality-adjusted life year (QALY) gained over 24 months will be estimated within trial, and incremental cost per QALY gained over 20 years by KJD relative to KR predicted using decision analytic modelling.Ethics and dissemination Ethics approval was obtained from the Research Ethics Committee (REC) and Health Research Authority (HRA). Trial results will be disseminated at clinical conferences, through relevant patient groups and published in peer-reviewed journals.Trial registration number ISRCTN14879004; recruitment opened April 2021.https://bmjopen.bmj.com/content/12/6/e062721.full
spellingShingle Deborah D Stocken
Dennis G McGonagle
David Murray
Catherine Reynolds
Catherine Fernandez
David R Ellard
Andrew Metcalfe
Hemant Sharma
Paul Harwood
Hamish Simpson
Hemant Pandit
Susanne Arnold
Cerys Joyce Tassinari
Ruchi Higham
Isabelle Louise Smith
Ruben Mujica-Mota
Thomas William Hamilton
Julie Croft
Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
BMJ Open
title Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
title_full Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
title_fullStr Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
title_full_unstemmed Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
title_short Clinical and cost-effectiveness of Knee Arthroplasty versus Joint Distraction for Osteoarthritis (KARDS): protocol for a multicentre, phase III, randomised control trial
title_sort clinical and cost effectiveness of knee arthroplasty versus joint distraction for osteoarthritis kards protocol for a multicentre phase iii randomised control trial
url https://bmjopen.bmj.com/content/12/6/e062721.full
work_keys_str_mv AT deborahdstocken clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT dennisgmcgonagle clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT davidmurray clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT catherinereynolds clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT catherinefernandez clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT davidrellard clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT andrewmetcalfe clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT hemantsharma clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT paulharwood clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT hamishsimpson clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT hemantpandit clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT susannearnold clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT cerysjoycetassinari clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT ruchihigham clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT isabellelouisesmith clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT rubenmujicamota clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT thomaswilliamhamilton clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial
AT juliecroft clinicalandcosteffectivenessofkneearthroplastyversusjointdistractionforosteoarthritiskardsprotocolforamulticentrephaseiiirandomisedcontroltrial